|
|
Regional Indicator
Based on Pharmacy Purchases
November '99 - October '00 for
11 leading
countries world wide *
 
|
|
Regions
Drug
sales through retail pharmacies in thirteen key markets closed
at $221.3 billion, an 11% growth for the twelve-month period
from November 1999 through to October 2000.
- Retail
pharmacy drug sales for the 13 major markets edged up to
11% sales growth for the first time.
- North
America continues to experience the most significant growth,
posting 15% sales growth and $101.2 billion in sales in
the 12 months to October.
- Sales
in the top five European markets have maintained the 8%
growth rate, as recorded last month. Germany, United Kingdom
and Spain are all showing particular improvement up by 1%
at 5% (Germany) and 9% (UK & Spain) respectively.
- The
Japanese market now valued at $52 billion and advancing
to 2nd position in the world market, pushing Europe back
to 3rd place at $51.7 billion in sales, shows an overall
1% increase in the rate of growth from 4% to 5% in the 12
months to October.
- Growth
in the leading three Latin American markets continues to
improve, now up to 8%, to $13.4 billion - a 2% growth increase
over the previous month. Brazil, reported a positive growth
rate at 2% for the first time, compared to a fall of 24%
in the like year-earlier period.
- In
the Australia/New Zealand market sales are growing sharply
at 12% to $2.9 billion, with an 1% uptick in sales growth
from last month.
|
|
See also top products,
corporations and therapy
areas.
A
detailed report of sales for the Top
20 Countries in 1998 and 1999 is available to buy online.
* Source: IMS Monthly
Midas. Any use of this information
must be sourced to IMS HEALTH.
Please note data
collection, values and definitions.
|
|
|
|
